Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy.

Abstract

For control of DSRCT, our experience supports intensive use of HD-CAV, aggressive surgery to resect visible disease, radiotherapy to high-risk sites, and myeloablative chemotherapy with stem-cell rescue in selected cases.